Centre De Recherche De L'hopital Douglas

Centre De Recherche De L'Hopital Douglas is a Canadian non-profit research organization located in Verdun, Quebec, focusing on advanced medical and neuroscience research. Registered in the System for Award Management (SAM.gov) since January 2014, the organization is an international entity specializing in scientific research, particularly in the domains of mental health and neurological studies. Its research infrastructure and capabilities enable it to conduct sophisticated scientific investigations that contribute to understanding complex medical conditions and potential treatment strategies.

The organization has been actively engaged in federal grant awards, primarily from the National Institute of Mental Health (NIMH), focusing on cutting-edge neurological and psychiatric research. Significant grant awards include a $535,153 project grant to conduct large-scale, single-cell characterization of molecular networks in major depressive disorder, investigating transcriptomic changes across brain regions and exploring the impact of genetic ancestry and sex on these changes. Another notable $1,537,147 grant involved using positron emission tomography (PET) to investigate the endocannabinoid system's role in depression and suicide, specifically examining the enzyme fatty acid amide hydrolase (FAAH). The Centre has collaborated with prime grantees like Washington University and Icahn School of Medicine at Mount Sinai on various research projects, including studies on early course psychosis, cognitive assessments, and neurological research. These grants demonstrate the organization's expertise in advanced neurological research, molecular biology, and sophisticated medical imaging techniques, with a particular emphasis on understanding mental health conditions at the cellular and molecular levels.